RU2167150C2 - Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity - Google Patents

Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity Download PDF

Info

Publication number
RU2167150C2
RU2167150C2 RU98105448/04A RU98105448A RU2167150C2 RU 2167150 C2 RU2167150 C2 RU 2167150C2 RU 98105448/04 A RU98105448/04 A RU 98105448/04A RU 98105448 A RU98105448 A RU 98105448A RU 2167150 C2 RU2167150 C2 RU 2167150C2
Authority
RU
Russia
Prior art keywords
polyfluoroalkyl
arylcarbamates
antibacterial activity
nhcoochr
showing antibacterial
Prior art date
Application number
RU98105448/04A
Other languages
Russian (ru)
Other versions
RU98105448A (en
Inventor
А.В. Фокин
Ю.Н. Студнев
А.П. Краснов
Г.Г. Розанцев
В.А. Фроловский
ров В.П. Стол
В.П. Столяров
О.Ф. Кинаш
Original Assignee
Фокин Александр Васильевич
Студнев Юлий Николаевич
Краснов Александр Петрович
Розанцев Григорий Григорьевич
Фроловский Вадим Александрович
Столяров Виктор Петрович
Кинаш Олег Федорович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фокин Александр Васильевич, Студнев Юлий Николаевич, Краснов Александр Петрович, Розанцев Григорий Григорьевич, Фроловский Вадим Александрович, Столяров Виктор Петрович, Кинаш Олег Федорович filed Critical Фокин Александр Васильевич
Priority to RU98105448/04A priority Critical patent/RU2167150C2/en
Publication of RU98105448A publication Critical patent/RU98105448A/en
Application granted granted Critical
Publication of RU2167150C2 publication Critical patent/RU2167150C2/en

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

FIELD: organic chemistry. SUBSTANCE: invention describes novel polyfluoroalkyl-N-arylcarbamates of the general formula: RR′C6H3NHCOOCHR″R″′ where R, R' mean H, ortho-, meta- or para-alkyl-C1-C3, CF3, CH3S, Cl, NO2, NHCOOCHR''R'''; R'' means H, CF3; R''' means CF3, (CF2)nH where n = 2-6 or CF2NO2 with the exception of 2,2-difluoro-2-nitroethyl-N-phenylcarbamate, 2,2,2-trifluoroethyl-N-p-nitrophenylcarbamate showing the broad spectrum of antibacterial effect at low toxicity that can be used in medicine. EFFECT: new compounds indicated above, valuable properties. 2 tbl

Description

Изобретение относится к применению фторсодержащих производных карбаминовой кислоты, а именно полифторалкил-N-арилкарбаматов общей формулы

Figure 00000001

где R и R' = H, о-, м или п-алкил C1-C3, CF3, CH3S, Cl, NO2, NHCOOCHR''R''';
R'' = H, CF3;
R''' = CF3, (CF2)nH, где n = 2-6, или CF2NO2 за исключением 2.2-дифтор-2-нитроэтил-N-фенилкарбамата, 2.2.2-трифторэтил-N-п-нитрофенилкарбамата,
обладающие антимикробной активностью.The invention relates to the use of fluorine derivatives of carbamic acid, namely polyfluoroalkyl-N-arylcarbamates of the general formula
Figure 00000001

where R and R '= H, o-, m or p-alkyl C 1 -C 3 , CF 3 , CH 3 S, Cl, NO 2 , NHCOOCHR "R"'';
R "= H, CF 3 ;
R '''= CF 3 , (CF 2 ) n H, where n = 2-6, or CF 2 NO 2 with the exception of 2.2-difluoro-2-nitroethyl-N-phenylcarbamate, 2.2.2-trifluoroethyl-N-p nitrophenyl carbamate,
possessing antimicrobial activity.

Описано использование бис-(карбаматов) из высших (≥ C10) полифторалканолов и толуилендиизоцианата, используемых для придания тканям водо- и маслоотталкивающих свойств [Пат. США N 3171861, опубл. 1965]. Последние соединения выходят за пределы формулы (1) - более высшие спирты. Сведения об антимикробной активности полифторалкил-N-арилкарбаматов в литературе отсутствуют.The use of bis- (carbamates) from higher (≥ C 10 ) polyfluoroalkanols and toluene diisocyanate used to impart water- and oil-repellent properties to tissues is described [Pat. United States N 3171861, publ. 1965]. The latter compounds go beyond the formula (1) - higher alcohols. Information on the antimicrobial activity of polyfluoroalkyl-N-arylcarbamates is not available in the literature.

Задачей предлагаемого изобретения является создание принципиально новых веществ с высокой антимикробной активностью широкого спектра действия, отличающихся исключительно низкой токсичностью и совершенно не опасных для человека. The objective of the invention is to create a fundamentally new substances with high antimicrobial activity of a wide spectrum of action, characterized by extremely low toxicity and completely harmless to humans.

Сущность предлагаемого изобретения достигается сочетанием в предлагаемых соединениях ароматического заместителя у атома азота и ≥ 2 атомов фтора в β-положении алкильного у остатка, что ведет к проявлению ими антимикробных свойств. Замена N-арильного заместителя на бензил или пиперидил (соединения 25 и 26, табл. N 1) резко снижает их антимикробную активность. Более удаленное расположение атомов фтора (по сравнению с β-положением) также снижает бактерицидность (см. соединение 27 табл. N 1). The essence of the invention is achieved by combining in the proposed compounds an aromatic substituent at the nitrogen atom and ≥ 2 fluorine atoms in the β-position of the alkyl at the residue, which leads to their manifestation of antimicrobial properties. Replacing the N-aryl substituent with benzyl or piperidyl (compounds 25 and 26, Table N 1) sharply reduces their antimicrobial activity. A more remote arrangement of fluorine atoms (compared with the β-position) also reduces bactericidal activity (see compound 27 of table. N 1).

Методика исследования антибактериальной активности. The methodology for the study of antibacterial activity.

Антимикробную активность синтезированных соединений исследовали в плотной питательной среде методом "диффузии в агаре" или луночным методом. The antimicrobial activity of the synthesized compounds was studied in a dense nutrient medium by the method of "diffusion in agar" or by the hole method.

Поверхность чашки Петри с твердым питательным агаром засевают сплошным "газоном" взвеси суточной культуры по бактериальному стандарту. Чашку подсушивают 40 мин в термостате, затем в середину чашки в лунку вносят по 3 капли раствора исследуемого вещества (10%, 1% или 0.1%) и чашку термостатируют при 37oC 24 ч.The surface of the Petri dish with solid nutrient agar is seeded with a continuous "lawn" suspension of daily culture according to the bacterial standard. The cup is dried for 40 minutes in a thermostat, then 3 drops of a solution of the test substance (10%, 1% or 0.1%) are added to the well in the middle of the cup and the cup is thermostated at 37 ° C for 24 hours.

Результаты исследования оценивают визуально, измеряя зоны задержки роста микробов после инкубации. The results of the study are evaluated visually by measuring areas of growth inhibition of microbes after incubation.

Для испытаний использованы грамположительные бактерии - стафилококк белый, стафилококк золотистый (906), палочка антракоида (1312) и грамотрицательная кишечная палочка (25922). Результаты приведены в табл. N 1. Gram-positive bacteria were used for the tests: white staphylococcus, Staphylococcus aureus golden (906), anthracoid bacillus (1312) and gram-negative Escherichia coli (25922). The results are shown in table. N 1.

Некоторые из синтезированных соединений испытаны на патогенных грибах - Candida albicaus ATCC 885-653 - одноклеточные дрожжеподобные грибы, и показали активность средней силы. Some of the synthesized compounds were tested on pathogenic fungi — Candida albicaus ATCC 885-653 — unicellular yeast-like fungi, and showed moderate potency.

Как следует из данных табл. N 1 заявляемые полифторалкил-N-арилкарбаматы по своей антимикробной активности конкурентноспособны с известными бактерицидами как фенол, монохлорамин (ДТ-1) и даже K-соль пенициллина. As follows from the data table. N 1 claimed polyfluoroalkyl-N-aryl carbamates in their antimicrobial activity are competitive with known bactericides like phenol, monochloramine (DT-1) and even the K-salt of penicillin.

Результаты биологических исследований, приведенные в табл. N 1, свидетельствуют, что высокая антимикробная активность и низкая токсичность заявляемых веществ делает возможным их использование в качестве химиотерапевтических и антисептических средств для медицинской практики, в частности для профилактики бактериальных инфекций и грибковых поражений на поверхности. The results of biological studies are given in table. N 1, indicate that the high antimicrobial activity and low toxicity of the claimed substances makes it possible to use them as chemotherapeutic and antiseptic agents for medical practice, in particular for the prevention of bacterial infections and fungal infections on the surface.

Пример. К 0.9 г фенилизоцианата добавили 2.5 г 1,1,7-тригидрододекафторгептанола-1 и 3 капли триэтиламина, после окончания экзотермической реакции смесь нагревают 1 ч на кипящей водяной бане и кристаллизуют из гексана. Выход 2.6 г (76.5%) 1,1,7-тригидрододекафторгептанил-N-фенилкарбамата, т.пл. 47-48oC. Аналогично получены другие соединения, представленные в табл. N 2.Example. 2.5 g of 1,1,7-trihydrododecafluoroheptanol-1 and 3 drops of triethylamine were added to 0.9 g of phenylisocyanate; after the end of the exothermic reaction, the mixture was heated for 1 h in a boiling water bath and crystallized from hexane. Yield 2.6 g (76.5%) of 1,1,7-trihydrododecafluoroheptanyl-N-phenylcarbamate, mp. 47-48 o C. Similarly, other compounds are presented, are presented in table. N 2.

Свойства полученных соединений и их выход приведены в табл. N 2. The properties of the obtained compounds and their yield are given in table. N 2.

Claims (1)

Полифторалкил-N-арилкарбаматы формулы I
Figure 00000002

где R, R'= H, o-, м-, или п-алкил C1-C3, CF3, CH3S, Cl, NO, NHCOOCHR''R''';
R''=H,CF;
R'''= CF3, (CF2)nH, где n = 2 - 6, или CF2NO2, за исключением 2,2-дифтор-2-нитроэтил-N-фенилкарбамата, 2,2,2-трифторэтил-N-n-нитрофенилкарбамата,
обладающие антимикробной активностью.
Polyfluoroalkyl-N-arylcarbamates of Formula I
Figure 00000002

where R, R '= H, o-, m-, or p-alkyl C 1 -C 3 , CF 3 , CH 3 S, Cl, NO, NHCOOCHR "R"'';
R "= H, CF;
R '''= CF 3 , (CF 2 ) n H, where n = 2-6, or CF 2 NO 2 , with the exception of 2,2-difluoro-2-nitroethyl-N-phenylcarbamate, 2,2,2- trifluoroethyl-Nn-nitrophenylcarbamate,
possessing antimicrobial activity.
RU98105448/04A 1998-03-25 1998-03-25 Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity RU2167150C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98105448/04A RU2167150C2 (en) 1998-03-25 1998-03-25 Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98105448/04A RU2167150C2 (en) 1998-03-25 1998-03-25 Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity

Publications (2)

Publication Number Publication Date
RU98105448A RU98105448A (en) 1999-12-20
RU2167150C2 true RU2167150C2 (en) 2001-05-20

Family

ID=20203847

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98105448/04A RU2167150C2 (en) 1998-03-25 1998-03-25 Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity

Country Status (1)

Country Link
RU (1) RU2167150C2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2515896C2 (en) * 2008-08-08 2014-05-20 Байер Матириальсайенс Аг Urethane acrylates based on phenylisocyanate, method for production thereof, use thereof to produce holographic media or photopolymer films, method of coating holographic media and photopolymer films and moulded components based on said urethane acrylates
EP2800565A1 (en) * 2012-01-06 2014-11-12 Abide Therapeutics, Inc. Carbamate compounds and of making and using same
US9771341B2 (en) 2015-03-18 2017-09-26 Abide Therapeutics, Inc. Piperazine carbamates and methods of making and using same
US9981930B1 (en) 2016-11-16 2018-05-29 Abide Therapeutics, Inc. MAGL inhibitors
US10093635B2 (en) 2016-11-16 2018-10-09 Abide Therapeutics, Inc. MAGL inhibitors
US10450302B2 (en) 2015-05-11 2019-10-22 Lundbeck La Jolla Research Center, Inc. Methods of treating inflammation or neuropathic pain
US10463753B2 (en) 2016-02-19 2019-11-05 Lundbeck La Jolla Research Center, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
US10570106B2 (en) 2018-05-15 2020-02-25 Lundbeck La Jolla Research Center, Inc. MAGL inhibitors
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
US11702393B2 (en) 2020-04-21 2023-07-18 H. Lundbeck A/S Synthesis of a monoacylglycerol lipase inhibitor
US12018004B2 (en) 2022-11-08 2024-06-25 H. Lundbeck A/S Carbamate compounds and methods of making and using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HEGARTY F. ET AL. Elimination-Addition Mechanism for the Hydrolysis of Carbamates. JOURNAL OF THE CHEMICAL SOCIETY, Perkin Trans. II.-1973, № 12, p.1727. *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2515896C2 (en) * 2008-08-08 2014-05-20 Байер Матириальсайенс Аг Urethane acrylates based on phenylisocyanate, method for production thereof, use thereof to produce holographic media or photopolymer films, method of coating holographic media and photopolymer films and moulded components based on said urethane acrylates
US9487495B2 (en) 2012-01-06 2016-11-08 The Scripts Research Institute Carbamate compounds and of making and using same
CN104159581A (en) * 2012-01-06 2014-11-19 阿比德治疗公司 Carbamate compounds and of making and using same
EP2800565A4 (en) * 2012-01-06 2015-04-29 Abide Therapeutics Inc Carbamate compounds and of making and using same
US9133148B2 (en) 2012-01-06 2015-09-15 The Scripps Research Institute Carbamate compounds and of making and using same
AU2013207252B2 (en) * 2012-01-06 2016-06-09 H.Lundbeck A/S Carbamate compounds and pharmaceutical compositions thereof
US11021453B2 (en) 2012-01-06 2021-06-01 Lundbeck La Jolla Research Center, Inc. Carbamate compounds and methods of making and using same
US9957242B2 (en) 2012-01-06 2018-05-01 The Scripps Research Institute Carbamate compounds and methods of making and using same
CN107982266A (en) * 2012-01-06 2018-05-04 阿比德治疗公司 Carbamate compounds and its preparation and application
US11530189B2 (en) 2012-01-06 2022-12-20 H. Lundbecka/S Carbamate compounds and methods of making and using same
EP2800565A1 (en) * 2012-01-06 2014-11-12 Abide Therapeutics, Inc. Carbamate compounds and of making and using same
US9771341B2 (en) 2015-03-18 2017-09-26 Abide Therapeutics, Inc. Piperazine carbamates and methods of making and using same
US9994537B2 (en) 2015-03-18 2018-06-12 Abide Therapeutics, Inc. Piperazine carbamates and methods of making and using same
US11034674B2 (en) 2015-05-11 2021-06-15 H. Lundbeck A/S Methods of treating inflammation or neuropathic pain
US10450302B2 (en) 2015-05-11 2019-10-22 Lundbeck La Jolla Research Center, Inc. Methods of treating inflammation or neuropathic pain
US10463753B2 (en) 2016-02-19 2019-11-05 Lundbeck La Jolla Research Center, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
US10093635B2 (en) 2016-11-16 2018-10-09 Abide Therapeutics, Inc. MAGL inhibitors
US9981930B1 (en) 2016-11-16 2018-05-29 Abide Therapeutics, Inc. MAGL inhibitors
US10570106B2 (en) 2018-05-15 2020-02-25 Lundbeck La Jolla Research Center, Inc. MAGL inhibitors
US11214557B2 (en) 2018-05-15 2022-01-04 H. Lundbeck A/S MAGL inhibitors
US11332453B2 (en) 2018-05-15 2022-05-17 H. Lundbeck A/S MAGL inhibitors
US11702393B2 (en) 2020-04-21 2023-07-18 H. Lundbeck A/S Synthesis of a monoacylglycerol lipase inhibitor
US12018004B2 (en) 2022-11-08 2024-06-25 H. Lundbeck A/S Carbamate compounds and methods of making and using same

Similar Documents

Publication Publication Date Title
JP3204962B2 (en) Quaternary ammonium polymer trihalides and uses thereof
RU2167150C2 (en) Polyfluoroalkyl-n-arylcarbamates showing antibacterial activity
US20030032765A1 (en) Antimicrobial polymer
BRPI0617446A2 (en) amphoteric compound, use thereof, methods for the control of phytopathogenic fungi and bacteria and / or the mitigation of abiotic and biatic stress in agricultural crops, and for the stimulation of natural defense systems of abiotic and biotic stress plants and for induction of resistance in the crops themselves, fungicidal composition, and use of the composition
HU227487B1 (en) Fungicidal compositions based on (n-phenylacetyl-n-2,6-xylyl)methyl alaninate (benalaxyl), use thereof
RU2039036C1 (en) Biocidal composition and method of inhibiting growth of microorganisms in media
WO2019022637A1 (en) Antiseptic medicinal agent
US5420350A (en) Bis-biguanide compound useful as a disinfectant
GB2058071A (en) N-aryl-N-acyl-3-amino-oxazolidin- 2-one fungicides
US4472404A (en) 8-Quinolinyl carbamates and their use as urinary tract antimicrobials
EP0160322B1 (en) Iodonium ylide compositions and method for antimicrobial use
US4477461A (en) N-Aryl-N-acyl-3-amino-1,3-oxazolidine-2-thiones having fungicidal activity
CA2166588A1 (en) Storage stable biocide composition and process for making the same
US3711271A (en) Method for controlling algae
US3936466A (en) 3-Chloro-tetrahydro-1,3-oxazines or oxazolidines spiro substituted
RU2773080C1 (en) Trimeric quaternary pyridinium salts with biocidal action
RU1781211C (en) N,n'-bis (vinylhydroxyethyl) thiuram-disulfide exhibiting fungicidal and bactericidal
US3991195A (en) Method of controlling bacteria
RU2365596C1 (en) Copolymers of diallylaminophosphonium salts with sulphur dioxide demonstrating anti-microbial activity
RU2287273C1 (en) Using n-substituted 3-cyano-4,6-dimethyl-5-chloropyridyl-2-sulfonylamides as antidotes of herbicide 2,4-dichlorophenoxyacetic acid in sunflower
RU2050352C1 (en) Diethyl aminomethyl urea as antimicrobic additive for cutting liquids
US4238503A (en) Anilide urea biocides
US3946016A (en) Fungicidal 8-quinolyl carbanilates
US3909231A (en) Cyano substituted malanilate biocides
RU2163236C2 (en) 1-(21-hydroxyphenyl)-2-methylpyrrole showing antibacterial activity

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20060326